Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19
Clinical trial NCT04895449 · COMPLETED
Trial details
- NCT number
- NCT04895449
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2022-11-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.